The role of GSK-3 in synaptic plasticity. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles British Journal of Pharmacology Year : 2008

The role of GSK-3 in synaptic plasticity.

Stéphane Peineau
Clarrisa Bradley


Glycogen synthase kinase-3 (GSK-3), an important component of the glycogen metabolism pathway, is highly expressed in the CNS. It has been implicated in major neurological disorders including Alzheimer's disease, schizophrenia and bipolar disorders. Despite its central role in these conditions it was not known until recently whether GSK-3 has neuronal-specific functions under normal conditions. However recent work has shown that GSK-3 is involved in the regulation of, and cross-talk between, two major forms of synaptic plasticity, N-methyl-D-aspartate receptor (NMDAR)-dependent long-term potentiation (LTP) and NMDAR-dependent long-term depression (LTD). The present article summarizes this recent work and discusses its potential relevance to the treatment of neurological disorders.
Fichier principal
Vignette du fichier
bjp_HAL.pdf (2.22 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-00777058 , version 1 (16-01-2013)



Stéphane Peineau, Clarrisa Bradley, Changiz Taghibiglou, Andrew Doherty, Zuner A. Bortolotto, et al.. The role of GSK-3 in synaptic plasticity.. British Journal of Pharmacology, 2008, 153 Suppl 1, pp.S428-37. ⟨10.1038/bjp.2008.2⟩. ⟨inserm-00777058⟩


98 View
285 Download



Gmail Facebook X LinkedIn More